^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners
    DRUG:

    ezetimibe/simvastatin

    i
    Other names: MK-0653A
    Company:
    Generic mfg.
    Drug class:
    HMG-CoA reductase inhibitor, Cholesterol absorption inhibitor
    Related drugs:
    over1year
    Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer (clinicaltrials.gov)
    P2, N=140, Recruiting, Cedars-Sinai Medical Center | Not yet recruiting --> Recruiting
    Enrollment open
    |
    CD8 (cluster of differentiation 8)
    |
    sirolimus • ezetimibe/simvastatin
    over1year
    Intensive Cholesterol-Lowering and CD8+ T Cells in Prostate Cancer (clinicaltrials.gov)
    P2, N=140, Not yet recruiting, Cedars-Sinai Medical Center
    New P2 trial
    |
    CD8 (cluster of differentiation 8)
    |
    sirolimus • ezetimibe/simvastatin
    over1year
    To Study the Effect of Vytorin on Intracellular Lipid and Inflammation in Obese Subjects (clinicaltrials.gov)
    P=N/A, N=20, Completed, University at Buffalo | Unknown status --> Completed | Phase classification: P3 --> PN/A
    Trial completion • Phase classification
    |
    CD68 (CD68 Molecule)
    |
    ezetimibe/simvastatin